Newsroom
Sorted by: Latest
-
Samenvatting: Siemens onthult technologieën om de industriële AI-revolutie te versnellen op CES 2026
LAS VEGAS--(BUSINESS WIRE)--Op CES 2026 luidde de keynote van Siemens een nieuw tijdperk van technologie voor de industrie en infrastructuur in. Dit liet zien hoe klanten en partners kunstmatige intelligentie inzetten om hun bedrijven te transformeren. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is....
-
Allied Services Group (“Allied”) Acquires Substations, Inc. (“SSI”), Expanding Its Service Capabilities Into Texas
BOSTON--(BUSINESS WIRE)--Allied Services Group (“Allied”), a platform company of the investment firm Bear Castle Capital (“Bear Castle”), has acquired Substations, Inc. (“SSI”). Allied is a market-leading contractor for a wide array of electrical solutions. At present, Allied serves a diverse customer base across five states in the Western and Southern United States. Founded in 2013, SSI specializes in high voltage substation and switchyard installation, modifications and maintenance services a...
-
Johnston Tobey Baruch’s Robert Tobey Selected to 2026 Lawdragon Hall of Fame
DALLAS--(BUSINESS WIRE)--Johnston Tobey Baruch shareholder and veteran trial lawyer Robert Tobey has been singled out for his exceptional contributions to the legal profession, earning selection to the prestigious Lawdragon Hall of Fame for 2026. Mr. Tobey, who has been named multiple times to Lawdragon’s 500 Leading Lawyers in America list, was recognized for his litigation expertise. “I’m honored to be included in Lawdragon’s 2026 Hall of Fame class,” said Mr. Tobey. “It is both humbling and...
-
Encore Oilfield Services, LLC Acquires Custom Compression Systems
NEW IBERIA, La.--(BUSINESS WIRE)--Encore Oilfield Services, LLC Announces Acquisition of Custom Compression Systems...
-
Samenvatting: ZIIHERA Plus TEVIMBRA en chemotherapie: een mogelijke nieuwe standaard voor eerstelijnsbehandeling van HER2+ gevorderde GEA
SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), een wereldwijd oncologiebedrijf, heeft vandaag de volledige resultaten bekendgemaakt van de fase 3-studie HERIZON-GEA-01 waarin ZIIHERA® (zanidatamab), een HER2-gericht bispecifiek antilichaam, werd beoordeeld in combinatie met chemotherapie, met en zonder PD-1-remmer TEVIMBRA® (tislelizumab), als eerstelijnsbehandeling voor HER2-positief (HER2+) lokaal gevorderd of gemetastaseerd gastro-oesofagea...
-
Hagens Berman: Montana Court Denies Motions to Dismiss Class-Action Lawsuit Fighting PFAS in Firefighter Turnout Gear
BUTTE, Mont.--(BUSINESS WIRE)--A Montana federal judge denied motions to dismiss a class-action lawsuit brought by Hagens Berman to combat toxic PFAS in firefighter turnout gear....
-
Acclaimed Attorney Charla Aldous Selected to Lawdragon’s Hall of Fame
DALLAS--(BUSINESS WIRE)--Veteran trial attorney Charla Aldous, founder of the personal injury boutique firm Aldous Law and a pacesetter among Texas attorneys for more than three decades, has been selected to the 12th annual class of the Lawdragon Hall of Fame. Lawdragon, which publishes renowned lawyer guides and legal industry content, has singled out for national recognition the top U.S. legal practitioners each year since 2015. Ms. Aldous is among fewer than two dozen Dallas-based attorneys...
-
Westinghouse Announces New Chief Legal Officer
CRANBERRY TOWNSHIP, Pa.--(BUSINESS WIRE)--Westinghouse Electric Company announced the appointment of Justin Johnson as executive vice president and Chief Legal Officer. He takes over the role following the announced retirement of Michael Sweeney. In this position, Mr. Johnson will be responsible for overseeing all legal and compliance operations for the company’s global businesses. He will join the executive leadership team reporting to Westinghouse Interim Chief Executive Officer Dan Sumner. “...
-
Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients
LYON, France--(BUSINESS WIRE)--Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the first dose levels in its ongoing first-in-human study. The multi-center, open-label trial (NCT06934538) is a phase Ia/Ib study designed to evaluate safety, tolerability and preliminary clinical activity of STC-10101 in a first line setting. It will include in vivo analysis of immune and tumor dynamics during do...
-
Libertas Funding Crosses $5 Billion Milestone
GREENWICH, Conn.--(BUSINESS WIRE)--Libertas Funding has crossed $5 billion in total funding in less than ten years, reinforcing its position as a leading growth capital partner for small and medium-sized businesses. "We built Libertas to prove that speed and sophistication aren't mutually exclusive," said Gary Katcher, Founder and Executive Chairman. "We treat business owners like partners. $5 billion in under ten years proves the market wants something better—and we deliver it." Our growth tra...